Reassessing Twenty Years of Vaccine Development Against Tuberculosis
Tuberculosis (TB) remains the prime bacterial infection worldwide with 10.4 million infections and a death toll of 1.7 million people in 2016 according to WHO statistics. Tuberculosis is caused by members of the Mycobacterium tuberculosis complex, facultative intracellular bacteria able to thrive wi...
Guardado en:
Autor principal: | Stefan H. Kaufmann (auth) |
---|---|
Otros Autores: | Ulrich E. Schaible (auth) |
Formato: | Electrónico Capítulo de libro |
Lenguaje: | inglés |
Publicado: |
Frontiers Media SA
2018
|
Colección: | Frontiers Research Topics
|
Materias: | |
Acceso en línea: | DOAB: download the publication DOAB: description of the publication |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Protective Immune Response to Dengue Virus Infection and Vaccines: perspectives from the field to the bench
por: Scott Halstead
Publicado: (2015) -
Host-Directed Therapies for Tuberculosis
Publicado: (2020) -
Tuberculosis in Adults and Children
por: Caws, Maxine
Publicado: (2015) -
Tuberculosis in Adults and Children
por: Caws, Maxine
Publicado: (2015) -
Continued Learning of Tissue-specific Immunity from the Immuno-Pathological Spectrum of Leprosy
Publicado: (2020)